Racial Disparities in Survival After Diagnosis of Prostate Cancer in Kentucky, 2001-2010

Samuel Antwi, Thomas C. Tucker, Ann L. Coker, Steve T. Fleming

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Whether the African American race remains a significant predictor of poorer prostate cancer survival after adjusting for other sociodemographic and treatment-related factors remains unclear. We examined whether disparities in survival among 18,900 African American and Caucasian men diagnosed with prostate cancer in Kentucky remained after adjusting for health insurance (payor source), cancer treatment, cancer stage at diagnosis, prostate-specific antigen (PSA) level, smoking status, and Appalachian region. After adjusting for these predictors, African American men living in Kentucky had poorer prostate cancer survival after 5 years (hazard ratio [HR] = 1.33; 95% confidence interval = 1.11, 1.59) and 10 years (HR = 1.39; 95% CI = 1.18, 1.28) of follow-up, and for the entire follow-up period (HR = 1.41; 95% CI = 1.26, 1.65) compared to their Caucasian counterparts. Thus, health insurance status, cancer treatment, cancer stage at diagnosis, PSA level at diagnosis, smoking status, and geographic location did not explain the racial gap in survival in Kentucky.

Original languageEnglish (US)
Pages (from-to)306-316
Number of pages11
JournalAmerican Journal of Men's Health
Volume7
Issue number4
DOIs
StatePublished - Jul 2013
Externally publishedYes

Fingerprint

Prostatic Neoplasms
cancer
African Americans
Survival
Health Insurance
Prostate-Specific Antigen
Neoplasms
Appalachian Region
Smoking
Geographic Locations
Insurance Coverage
Caucasian
health insurance
smoking
Health Status
Therapeutics
Confidence Intervals
confidence
American

Keywords

  • Blacks
  • disparities
  • oncology
  • prostate cancer
  • race
  • survival

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health(social science)

Cite this

Racial Disparities in Survival After Diagnosis of Prostate Cancer in Kentucky, 2001-2010. / Antwi, Samuel; Tucker, Thomas C.; Coker, Ann L.; Fleming, Steve T.

In: American Journal of Men's Health, Vol. 7, No. 4, 07.2013, p. 306-316.

Research output: Contribution to journalArticle

Antwi, Samuel ; Tucker, Thomas C. ; Coker, Ann L. ; Fleming, Steve T. / Racial Disparities in Survival After Diagnosis of Prostate Cancer in Kentucky, 2001-2010. In: American Journal of Men's Health. 2013 ; Vol. 7, No. 4. pp. 306-316.
@article{f5cc949fce044202b31f68115169c2e5,
title = "Racial Disparities in Survival After Diagnosis of Prostate Cancer in Kentucky, 2001-2010",
abstract = "Whether the African American race remains a significant predictor of poorer prostate cancer survival after adjusting for other sociodemographic and treatment-related factors remains unclear. We examined whether disparities in survival among 18,900 African American and Caucasian men diagnosed with prostate cancer in Kentucky remained after adjusting for health insurance (payor source), cancer treatment, cancer stage at diagnosis, prostate-specific antigen (PSA) level, smoking status, and Appalachian region. After adjusting for these predictors, African American men living in Kentucky had poorer prostate cancer survival after 5 years (hazard ratio [HR] = 1.33; 95{\%} confidence interval = 1.11, 1.59) and 10 years (HR = 1.39; 95{\%} CI = 1.18, 1.28) of follow-up, and for the entire follow-up period (HR = 1.41; 95{\%} CI = 1.26, 1.65) compared to their Caucasian counterparts. Thus, health insurance status, cancer treatment, cancer stage at diagnosis, PSA level at diagnosis, smoking status, and geographic location did not explain the racial gap in survival in Kentucky.",
keywords = "Blacks, disparities, oncology, prostate cancer, race, survival",
author = "Samuel Antwi and Tucker, {Thomas C.} and Coker, {Ann L.} and Fleming, {Steve T.}",
year = "2013",
month = "7",
doi = "10.1177/1557988312473774",
language = "English (US)",
volume = "7",
pages = "306--316",
journal = "American Journal of Men's Health",
issn = "1557-9883",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Racial Disparities in Survival After Diagnosis of Prostate Cancer in Kentucky, 2001-2010

AU - Antwi, Samuel

AU - Tucker, Thomas C.

AU - Coker, Ann L.

AU - Fleming, Steve T.

PY - 2013/7

Y1 - 2013/7

N2 - Whether the African American race remains a significant predictor of poorer prostate cancer survival after adjusting for other sociodemographic and treatment-related factors remains unclear. We examined whether disparities in survival among 18,900 African American and Caucasian men diagnosed with prostate cancer in Kentucky remained after adjusting for health insurance (payor source), cancer treatment, cancer stage at diagnosis, prostate-specific antigen (PSA) level, smoking status, and Appalachian region. After adjusting for these predictors, African American men living in Kentucky had poorer prostate cancer survival after 5 years (hazard ratio [HR] = 1.33; 95% confidence interval = 1.11, 1.59) and 10 years (HR = 1.39; 95% CI = 1.18, 1.28) of follow-up, and for the entire follow-up period (HR = 1.41; 95% CI = 1.26, 1.65) compared to their Caucasian counterparts. Thus, health insurance status, cancer treatment, cancer stage at diagnosis, PSA level at diagnosis, smoking status, and geographic location did not explain the racial gap in survival in Kentucky.

AB - Whether the African American race remains a significant predictor of poorer prostate cancer survival after adjusting for other sociodemographic and treatment-related factors remains unclear. We examined whether disparities in survival among 18,900 African American and Caucasian men diagnosed with prostate cancer in Kentucky remained after adjusting for health insurance (payor source), cancer treatment, cancer stage at diagnosis, prostate-specific antigen (PSA) level, smoking status, and Appalachian region. After adjusting for these predictors, African American men living in Kentucky had poorer prostate cancer survival after 5 years (hazard ratio [HR] = 1.33; 95% confidence interval = 1.11, 1.59) and 10 years (HR = 1.39; 95% CI = 1.18, 1.28) of follow-up, and for the entire follow-up period (HR = 1.41; 95% CI = 1.26, 1.65) compared to their Caucasian counterparts. Thus, health insurance status, cancer treatment, cancer stage at diagnosis, PSA level at diagnosis, smoking status, and geographic location did not explain the racial gap in survival in Kentucky.

KW - Blacks

KW - disparities

KW - oncology

KW - prostate cancer

KW - race

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84880840092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880840092&partnerID=8YFLogxK

U2 - 10.1177/1557988312473774

DO - 10.1177/1557988312473774

M3 - Article

C2 - 23339130

AN - SCOPUS:84880840092

VL - 7

SP - 306

EP - 316

JO - American Journal of Men's Health

JF - American Journal of Men's Health

SN - 1557-9883

IS - 4

ER -